Copyright Reports & Markets. All rights reserved.

Global Renin-Inhibitors Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Renin-Inhibitors Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 150mg/Tablet
    • 1.3.3 300mg/Tablet
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Renin-Inhibitors Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Age below 45
    • 1.4.3 Age 45-55
    • 1.4.4 Age 55-65
    • 1.4.5 Age above 65
  • 1.5 Global Renin-Inhibitors Market Size & Forecast
    • 1.5.1 Global Renin-Inhibitors Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Renin-Inhibitors Sales Quantity (2020-2031)
    • 1.5.3 Global Renin-Inhibitors Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Novartis
    • 2.1.1 Novartis Details
    • 2.1.2 Novartis Major Business
    • 2.1.3 Novartis Renin-Inhibitors Product and Services
    • 2.1.4 Novartis Renin-Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Novartis Recent Developments/Updates
  • 2.2 Noden Pharma
    • 2.2.1 Noden Pharma Details
    • 2.2.2 Noden Pharma Major Business
    • 2.2.3 Noden Pharma Renin-Inhibitors Product and Services
    • 2.2.4 Noden Pharma Renin-Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Noden Pharma Recent Developments/Updates

3 Competitive Environment: Renin-Inhibitors by Manufacturer

  • 3.1 Global Renin-Inhibitors Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Renin-Inhibitors Revenue by Manufacturer (2020-2025)
  • 3.3 Global Renin-Inhibitors Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Renin-Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Renin-Inhibitors Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Renin-Inhibitors Manufacturer Market Share in 2024
  • 3.5 Renin-Inhibitors Market: Overall Company Footprint Analysis
    • 3.5.1 Renin-Inhibitors Market: Region Footprint
    • 3.5.2 Renin-Inhibitors Market: Company Product Type Footprint
    • 3.5.3 Renin-Inhibitors Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Renin-Inhibitors Market Size by Region
    • 4.1.1 Global Renin-Inhibitors Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Renin-Inhibitors Consumption Value by Region (2020-2031)
    • 4.1.3 Global Renin-Inhibitors Average Price by Region (2020-2031)
  • 4.2 North America Renin-Inhibitors Consumption Value (2020-2031)
  • 4.3 Europe Renin-Inhibitors Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Renin-Inhibitors Consumption Value (2020-2031)
  • 4.5 South America Renin-Inhibitors Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Renin-Inhibitors Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Renin-Inhibitors Sales Quantity by Type (2020-2031)
  • 5.2 Global Renin-Inhibitors Consumption Value by Type (2020-2031)
  • 5.3 Global Renin-Inhibitors Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Renin-Inhibitors Sales Quantity by Application (2020-2031)
  • 6.2 Global Renin-Inhibitors Consumption Value by Application (2020-2031)
  • 6.3 Global Renin-Inhibitors Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Renin-Inhibitors Sales Quantity by Type (2020-2031)
  • 7.2 North America Renin-Inhibitors Sales Quantity by Application (2020-2031)
  • 7.3 North America Renin-Inhibitors Market Size by Country
    • 7.3.1 North America Renin-Inhibitors Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Renin-Inhibitors Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Renin-Inhibitors Sales Quantity by Type (2020-2031)
  • 8.2 Europe Renin-Inhibitors Sales Quantity by Application (2020-2031)
  • 8.3 Europe Renin-Inhibitors Market Size by Country
    • 8.3.1 Europe Renin-Inhibitors Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Renin-Inhibitors Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Renin-Inhibitors Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Renin-Inhibitors Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Renin-Inhibitors Market Size by Region
    • 9.3.1 Asia-Pacific Renin-Inhibitors Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Renin-Inhibitors Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Renin-Inhibitors Sales Quantity by Type (2020-2031)
  • 10.2 South America Renin-Inhibitors Sales Quantity by Application (2020-2031)
  • 10.3 South America Renin-Inhibitors Market Size by Country
    • 10.3.1 South America Renin-Inhibitors Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Renin-Inhibitors Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Renin-Inhibitors Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Renin-Inhibitors Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Renin-Inhibitors Market Size by Country
    • 11.3.1 Middle East & Africa Renin-Inhibitors Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Renin-Inhibitors Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Renin-Inhibitors Market Drivers
  • 12.2 Renin-Inhibitors Market Restraints
  • 12.3 Renin-Inhibitors Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Renin-Inhibitors and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Renin-Inhibitors
  • 13.3 Renin-Inhibitors Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Renin-Inhibitors Typical Distributors
  • 14.3 Renin-Inhibitors Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Renin-Inhibitors market size was valued at US$ 107 million in 2024 and is forecast to a readjusted size of USD 167 million by 2031 with a CAGR of 6.6% during review period.
    Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the kidneys in response to sympathetic activation, hypotension, and decreased sodium delivery to the distal renal tubule. Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.
    Global Renin-Inhibitors main player is Noden Pharma, etc. Noden Pharma is dominating the market. USA is the largest market, with a share nearly 45%.
    This report is a detailed and comprehensive analysis for global Renin-Inhibitors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Renin-Inhibitors market size and forecasts, in consumption value ($ Million), sales quantity (K Tablet), and average selling prices (USD/K Tablet), 2020-2031
    Global Renin-Inhibitors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Tablet), and average selling prices (USD/K Tablet), 2020-2031
    Global Renin-Inhibitors market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Tablet), and average selling prices (USD/K Tablet), 2020-2031
    Global Renin-Inhibitors market shares of main players, shipments in revenue ($ Million), sales quantity (K Tablet), and ASP (USD/K Tablet), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Renin-Inhibitors
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Renin-Inhibitors market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Noden Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Renin-Inhibitors market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    150mg/Tablet
    300mg/Tablet
    Market segment by Application
    Age below 45
    Age 45-55
    Age 55-65
    Age above 65
    Major players covered
    Novartis
    Noden Pharma
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Renin-Inhibitors product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Renin-Inhibitors, with price, sales quantity, revenue, and global market share of Renin-Inhibitors from 2020 to 2025.
    Chapter 3, the Renin-Inhibitors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Renin-Inhibitors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Renin-Inhibitors market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Renin-Inhibitors.
    Chapter 14 and 15, to describe Renin-Inhibitors sales channel, distributors, customers, research findings and conclusion.

    Buy now